Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Patients with rare diseases and cancers are being signed up to a massive genetic study that could improve the treatment of their conditions.

100,000 Genomes ProjectFrom today clinicians will be asking eligible patients from around the country for genetic samples as part of the national 100,000 Genomes Project. The project is run by Oxford University Hospitals Trust (OUH), with the laboratory a collaboration of the Oxford Molecular Diagnostics Centre (OMDC) at the John Radcliffe Hospital and Oxford University.

SRT nurses and Biorepository Technicians from the Nuffield Department of Surgical Sciences will play a key role by recruiting the patients and collecting the blood and tissue samples that will be used in the project.

The team will collect around 1,200 samples from about 600 cancer patients and around 2,000 samples from about 660 rare disease patients. Samples will also be taken for other types of analyses for further research and extensive clinical outcome data will be collected. All samples will be sequenced by Illumina, the 100,000 Genomes Project’s sequencing partner.

Read the full story on the OUH website.


Gene study offers new hope to cancer patients

One patient to benefit from a pilot study into genetic sequencing is Oxford University’s Professor Kevin Gatter, who was diagnosed with rare metastatic prostate cancer in December. Read the full story in the Oxford Mail.

Similar stories

NDS projects awarded CRUK Oxford Cancer Development Fund

Two research projects at the Nuffield Department of Surgical Sciences (NDS) have been awarded pump-prime funding from this year’s CRUK Oxford Centre Development Fund.

Study finds higher risk of all-cause mortality among paediatric cancer patients in LMICs during the pandemic

During the first nine months of the COVID-19 pandemic, paediatric cancer patients from lower- and middle-income countries (LMICs) faced a higher risk of all-cause mortality than those in high-income countries, according to an international study led by the University of Oxford.

Athena Swan Silver Award renewal for NDS

We're delighted to announce that we have been successful in the renewal of our Athena Swan Silver Award, recognising our work in advancing gender equality.

Study reveals that bone changes energy requirements of cancer cells to promote growth and survival

Interrogating metabolic cross-talk in the tumour-bone microenvironment, new research from the Edwards Group shows how the pentose phosphate pathway contributes to prostate cancer bone metastasis.

First-in-human implant of a “closed-loop” bioelectronic research system for investigating treatments for brain disorders

Researchers at Oxford University have implanted a novel closed-loop research platform for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in Parkinson’s-like Multiple Systems Atrophy (MSA).

FDA approves novel organ preservation device developed across Biomedical Engineering and Surgery

First therapeutic device developed within the Institute of Biomedical Engineering (IBME) and the Nuffield Department of Surgical Sciences (NDS) completes regulatory approval on both sides of the Atlantic.

Blog posts

Lights, camera, action! My journey into video production

Dr Hannah McGivern provides a 'behind-the-scenes' account of her experience producing the video 'Journey of a QUOD Sample: Donating to Transplant Research', supported by the funds from the University of Oxford Public Engagement with Research (PER) Seed Fund.

Mentoring in practice

NDS has launched a new, interdepartmental mentoring scheme called RECOGNISE. In this podcast, Gemma Horbatowski (HR Advisor) interviews Monica Dolton (Programme Manager and Research Project Manager) about her experiences of mentor-mentee relationships.

Wrap up of 2021

After a brilliant year of hard work and dedication, the SITU team has done some reflection on 2021, focusing on key events, trial progression, and more. Read on to discover how the year 2021 went for the SITU team...

Celebrating Anti-Bullying Week with words of kindness

Keeva Heap, who is undertaking a communications work experience placement at the Nuffield Department of Surgical Sciences (NDS), shares our words of kindness In honour of Anti-Bullying Week.

My virtual work experience with NDS and NDORMS

Louise Tan, a Year 12 student from Ballyclare in County Antrim, Northern Ireland, recently attended the joint NDS and NDORMS Virtual Work Experience. In this guest blog, Louise reflects on her experience.